{{Rsnum
|rsid=4374383
|Gene=MERTK
|Chromosome=2
|position=112013193
|Orientation=plus
|GMAF=0.4835
|Gene_s=MERTK
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.6 | 49.6 | 39.8
| HCB | 60.3 | 35.3 | 4.4
| JPT | 64.6 | 30.1 | 5.3
| YRI | 27.9 | 48.3 | 23.8
| ASW | 26.8 | 39.3 | 33.9
| CHB | 60.3 | 35.3 | 4.4
| CHD | 56.5 | 35.2 | 8.3
| GIH | 7.9 | 34.7 | 57.4
| LWK | 28.2 | 45.5 | 26.4
| MEX | 8.6 | 44.8 | 46.6
| MKK | 19.2 | 48.7 | 32.1
| TSI | 17.6 | 47.1 | 35.3
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22841784
  |Trait=Hepatitis C induced liver fibrosis
  |Title=Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.
  |RiskAllele=A
  |Pval=1E-9
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}